Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (6)

2022

  1. Differences in the diabetogenic effect of statins in patients with prediabetes. The PRELIPID study

    Medicina Clinica, Vol. 158, Núm. 11, pp. 531-539

2021

  1. High miR-133a levels in the circulation anticipates presentation of clinical events in familial hypercholesterolaemia patients

    Cardiovascular Research, Vol. 117, Núm. 1, pp. 109-122

2019

  1. VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia

    Atherosclerosis, Vol. 285, pp. 17-22

2017

  1. Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia

    Journal of Clinical Lipidology, Vol. 11, Núm. 1, pp. 260-271

2016

  1. PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia

    Atherosclerosis, Vol. 254, pp. 249-253

2015

  1. Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study

    International Journal of Cardiology, Vol. 201, pp. 79-84